June 21 (Reuters) - Genscript Biotech Corp :
* DUKE-NUS AND GENSCRIPT ANNOUNCE NOTICE OF ALLOWANCE FOR U.S. PATENT APPLICATION FOR SARS-COV-2 SURROGATE VIRUS NEUTRALIZATION TEST
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
精彩评论